Claude demonstrates de novo protein-binder design

Aug 19, 2026 — An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant ...Read more

## Definition [edit] The phrase "drug design" is similar to ligand "Ligand (biochemistry)") design (i.e., design of a molecule that will bind tightly to its target). Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, and side effects, that first must be optimized before a ligand can become a safe and effective drug. These other characteristics are often difficult to predict with rational design techniques. [...] A biomolecular target (most commonly a protein or a nucleic acid) is a key molecule involved in a particular metabolic or signaling pathway that is associated with a specific disease condition or pathology or to the infectivity or survival of a microbial pathogen. Potential drug targets are not necessarily disease causing but must by definition be disease modifying. In some cases, small molecules will be designed to enhance or inhibit the target function in the

Apr 13, 2018 — Drugs work by blocking, augmenting, or otherwise modifying the activity of a molecule (usually a protein) involved in a disease process ...Read more

## Claude's Post ### Claude 1d · An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that’s meant weeks or months of expert work per target. Working autonomously, Claude produced binders against 14 of 15 targets. Adaptyv Bio and Twist Bioscience then independently synthesized and tested the designs in the lab. Between 22% and 35% of Claude’s designs bound successfully. The typical rate in the field today is 10-15%. Importantly, protein binders are not drugs. Designing a high-affinity binder is just the first step in the process of developing a drug-like molecule. However, this establishes a strong foundation to work from, and we’re building on it. [...] stop-color='%2302ADFC'/%3E%3Cstop offset='.5' stop-color='%230866FF'/%3E%3Cstop offset='1' stop-color='%232B7EFF'/%3E%3C/linearGradient%3E%3C/defs%3E%3C/svg%3E) [...] id='paint1_radial_15251_63610' cx='0' cy='0' r='1' gradientUnits='userSpaceOnUse' gra

An important first step in the drug development process is designing a molecule that can bind tightly to its target. Traditionally, that's meant weeks or ...Read more

## What is a drug? Drugs are chemical or biological substances that have some kind physiological or chemical effect on the body. Their effects are intended to be beneficial but can cause harmful side effects in some people. They may be single compounds or a mixture of different compounds. All drugs interact with specific ‘targets’ in the body, with the aim of modifying their activity and often resulting in a therapeutic effect – such as pain relief or to treat conditions such as cancer. Drug targets are usually proteins but are in some cases small regions of DNA or RNA. Often, drugs work by stimulating or blocking the activity of their targets. ## How is a drug developed? [...] The first stage of the drug development process is drug discovery. In the past, some drugs have been discovered by accident – such as penicillin. Today, more systematic approaches are used. This can include: + high-throughput screening: which allows scientists to test thousands of potential targets w